BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36937903)

  • 1. Pathogenesis of pulmonary hypertension caused by left heart disease.
    Xiao M; Lai D; Yu Y; Wu Q; Zhang C
    Front Cardiovasc Med; 2023; 10():1079142. PubMed ID: 36937903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
    Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
    Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
    Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease.
    Charalampopoulos A; Lewis R; Hickey P; Durrington C; Elliot C; Condliffe R; Sabroe I; Kiely DG
    Front Med (Lausanne); 2018; 5():174. PubMed ID: 29928642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
    Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
    Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension associated with left-sided heart disease.
    Maeder MT; Schoch OD; Kleiner R; Joerg L; Weilenmann D; Swiss Society For Pulmonary Hypertension
    Swiss Med Wkly; 2017; 147():w14395. PubMed ID: 28102878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
    Wright SP; Moayedi Y; Foroutan F; Agarwal S; Paradero G; Alba AC; Baumwol J; Mak S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under pressure: pulmonary hypertension associated with left heart disease.
    Farber HW; Gibbs S
    Eur Respir Rev; 2015 Dec; 24(138):665-73. PubMed ID: 26621980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
    Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
    J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary hypertension associated with left heart disease (group 2)].
    Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
    Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of pulmonary hypertension due to left heart disease.
    Liu SF; Yan Y
    Animal Model Exp Med; 2022 Sep; 5(3):197-206. PubMed ID: 35234367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension associated with left heart disease.
    Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
    Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension associated with left heart disease.
    Adir Y; Amir O
    Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Huston JH; Shah SJ
    Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease.
    Lteif C; Ataya A; Duarte JD
    J Am Heart Assoc; 2021 Jun; 10(11):e020633. PubMed ID: 34032129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension due to left heart disease.
    Vachiéry JL; Tedford RJ; Rosenkranz S; Palazzini M; Lang I; Guazzi M; Coghlan G; Chazova I; De Marco T
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension due to left heart diseases.
    Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the clinical efficacy of specific phosphodiesterase inhibitor in patients with pulmonary hypertension due to left heart disease.
    Han B; Wang Q
    Exp Ther Med; 2018 Aug; 16(2):1175-1186. PubMed ID: 30112056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension.
    Martinez C; Tsugu T; Sugimoto T; Lancellotti P
    Curr Cardiol Rep; 2019 Nov; 21(12):151. PubMed ID: 31768665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.